AI assistant
Sending…
PFIZER INC — Director's Dealing 2008
Mar 4, 2008
29831_dirs_2008-03-03_08707f99-f9eb-48f0-80b0-77e1054799d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2008-02-28
Reporting Person: SUSMAN SALLY (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-28 | Common Stock | A | 16462 | — | Acquired | 16462.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-28 | Stock Appreciation Rights | $22.55 | A | 66607 | Acquired | 2013-02-28 | Common Stock (66607.00) | Direct |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units.
F2: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31